Involvement of M2-polarized macrophages in the ascites from advanced epithelial ovarian carcinoma in tumor progression via Stat3 activation

Cancer Science

Volumn 101, Issue 10, 2010, Pages 2128-2136

  Takaishi, Kiyomi ^a   Komohara, Yoshihiro ^a   Tashiro, Hironori ^a   Ohtake, Hideyuki ^a   Nakagawa, Takenobu ^a   Katabuchi, Hidetaka ^a   Takeya, Motohiro ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD163 ANTIGEN; CD68 ANTIGEN; COLONY STIMULATING FACTOR 1; CYCLIN D1; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH RELATED ONCOGENE ALPHA; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 19; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTRALIZING ANTIBODY; ONCOPROTEIN; SMALL INTERFERING RNA; STAT3 PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN; CXCL1 CHEMOKINE; CXCL1 PROTEIN, HUMAN; STAT3 PROTEIN, HUMAN;

ARTICLE; ASCITES; ASCITES TUMOR CELL; CANCER CELL CULTURE; CANCER GROWTH; CELL ACTIVATION; CELL INTERACTION; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MACROPHAGE; MITOSIS INHIBITION; OVARY CARCINOMA; PHENOTYPE; POLARIZATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; CARCINOMA; CELL COMMUNICATION; CELL POLARITY; CYTOLOGY; DISEASE COURSE; OVARY TUMOR; PATHOLOGY; PHYSIOLOGY;

ASCITES; CARCINOMA; CELL COMMUNICATION; CELL POLARITY; CHEMOKINE CXCL1; DISEASE PROGRESSION; FEMALE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; MACROPHAGES; OVARIAN NEOPLASMS; STAT3 TRANSCRIPTION FACTOR;

EID: 77957028841     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2010.01652.x     Document Type: Article

References (39)

1. Okamura H, Katabuchi H. Pathophysiological dynamics of human ovarian surface epithelial cells in epithelial ovarian carcinogenesis. Int Rev Cytol 2005, 242:1-54.
2. Bhoola S, Hoskins WJ. Diagnosis and management of epithelial ovarian cancer. Obstet Gynecol 2006, 107:1399-1410.
3. Shield K, Ackland ML, Ahmed N, Rice GE. Multicellular spheroids in ovarian cancer metastases: biology and pathology. Gynecol Oncol 2009, 113:143-148.
4. Okamura H, Katabuchi H, Kanzaki H. Macrophages in reproductive biology. The Macrophages 2002, 548-576. Lewis C, Burke B, In, eds, London, Oxford University Press
5. Wang X, Deavers M, Patenia R. Monocyte/macrophage and T-cell infiltrates in peritoneum of patients with ovarian cancer or benign pelvic disease. J Transl Med 2006, 4:30.
6. Robinson-Smith TM, Isaacsohn I, Mercer CA. Macrophages mediate inflammation-enhanced metastasis of ovarian tumors in mice. Cancer Res 2007, 67:5708-5716.
7. Hagemann T, Lawrence T, McNeish I. Re-educating tumor-associated macrophages by targeting NF-kappaB. J Exp Med 2008, 205:1261-1268.
8. Charles KA, Kulbe H, Soper R. The tumor-promoting actions of TNF-alpha involve TNFR1 and IL-17 in ovarian cancer in mice and humans. J Clin Invest 2009, 119:3011-3023.
9. Bak SP, Walters JJ, Takeya M, Conejo-Garcia JR, Berwin BL. Scavenger receptor-A-targeted leukocyte depletion inhibits peritoneal ovarian tumor progression. Cancer Res 2007, 67:4783-4789.
10. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003, 3:23-35.
11. Mantovani A, Schioppa T, Biswas SK, Marchesi F, Allavena P, Sica A. Tumor-associated macrophages and dendritic cells as prototypic type II polarized myeloid populations. Tumori 2003, 89:459-468.
12. Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 2004, 4:71-78.
13. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004, 25:677-686.
14. Hagemann T, Wilson J, Burke F. Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype. J Immunol 2006, 176:5023-5032.
15. Duluc D, Delneste Y, Tan F. Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells. Blood 2007, 110:4319-4330.
16. Komohara Y, Ohnishi K, Kuratsu J, Takeya M. Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas. J Pathol 2008, 216:15-24.
17. Kawamura K, Komohara Y, Takaishi K, Katabuchi H, Takeya M. Detection of M2 macrophages and colony-stimulating factor 1 expression in serous and mucinous ovarian epithelial tumors. Pathol Int 2009, 59:300-305.
18. Sica A, Bronte V. Altered macrophage differentiation and immune dysfunction in tumor development. J Clin Invest 2007, 117:1155-1166.
19. Maeda T, Tashiro H, Katabuchi H. Establishment of an immortalised human ovarian surface epithelial cell line without chromosomal instability. Br J Cancer 2005, 93:116-123.
20. Martinez FO, Gordon S, Locati M, Mantovani A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol 2006, 177:7303-7311.
21. Komohara Y, Takemura K, Lei XF. Delayed growth of EL4 lymphoma in SR-A-deficient mice is due to up-regulation of nitric oxide and IFN-gamma production by tumor-associated macrophages. Cancer Sci 2009, 100:2160-2166.
22. Komohara Y, Hirahara J, Horikawa T. AM-3K, an anti-macrophage antibody, recognizes CD163, a molecule associated with an anti-inflammatory macrophage phenotype. J Histochem Cytochem 2006, 54:763-771.
23. Xu W, Schlagwein N, Roos A, van den Berg TK, Daha MR, van Kooten C. Human peritoneal macrophages show functional characteristics of M-CSF-driven anti-inflammatory type 2 macrophages. Eur J Immunol 2007, 37:1594-1599.
24. Kujawski M, Kortylewski M, Lee H, Herrmann A, Kay H, Yu H. Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice. J Clin Invest 2008, 118:3367-3377.
25. Mytar B, Baj-Krzyworzeka M, Majka M, Stankiewicz D, Zembala M. Human monocytes both enhance and inhibit the growth of human pancreatic cancer in SCID mice. Anticancer Res 2008, 28:187-192.
26. Hagemann T, Lawrence T. Investigating macrophage and malignant cell interactions in vitro. Methods Mol Biol 2009, 512:325-332.
27. Niemand C, Nimmesgern A, Haan S. Activation of STAT3 by IL-6 and IL-10 in primary human macrophages is differentially modulated by suppressor of cytokine signaling 3. J Immunol 2003, 170:3263-3272.
28. Rosen DG, Mercado-Uribe I, Yang G. The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis. Cancer 2006, 107:2730-2740.
29. Gastl G, Plante M, Finstad CL. High IL-6 levels in ascites correlate with reactive thrombocytosis in patients with epithelial ovarian cancer. Br J Haematol 1993, 83:433-441.
30. Plante M, Rubin SC, Wong GY, Federici MG, Finstad CL, Gastl GA. Interleukin-6 level in serum and ascites as a prognostic factor in patients with epithelial ovarian cancer. Cancer 1994, 73:1882-1888.
31. Mustea A, Konsgen D, Braicu EI. Expression of IL-10 in patients with ovarian carcinoma. Anticancer Res 2006, 26:1715-1718.
32. Sozzani S, Luini W, Borsatti A. Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokaines. J Immunol 1997, 159:1993-2000.
33. Fimmel S, Devermann L, Herrmann A, Zouboulis C. GRO-alpha: a potential marker for cancer and aging silenced by RNA interference. Ann N Y Acad Sci 2007, 1119:176-189.
34. Yoshimura A. Signal transduction of inflammatory cytokines and tumor development. Cancer Sci 2006, 97:439-447.
35. Yu H, Kortylewski M, Pardoll D. Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nat Rev Immunol 2007, 7:41-51.
36. Syed V, Ulinski G, Mok SC, Ho SM. Reproductive hormone-induced, STAT3-mediated interleukin 6 action in normal and malignant human ovarian surface epithelial cells. J Natl Cancer Inst 2002, 94:617-629.
37. Silver DL, Naora H, Liu J, Cheng W, Montell DJ. Activated signal transducer and activator of transcription (STAT) 3: localization in focal adhesions and function in ovarian cancer cell motility. Cancer Res 2004, 64:3550-3558.
38. Duan Z, Foster R, Bell DA. Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer. Clin Cancer Res 2006, 12:5055-5063.
39. Jack GD, Zhang L, Friedman AD. M-CSF elevates c-Fos and phospho-C/EBPα(S21) via ERK whereas G-CSF stimulates SHP2 phosphorylation in marrow progenitors to contribute to myeloid lineage specification. Blood 2009, 114:2172-2180.